SYN-TECH Chem. & Pharm. Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
May 08, 2022
Share
SYN-TECH Chem. & Pharm. Co., Ltd. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was TWD 159.52 million compared to TWD 235.58 million a year ago. Net income was TWD 34.24 million compared to TWD 51.97 million a year ago. Basic earnings per share from continuing operations was TWD 0.85 compared to TWD 1.73 a year ago. Diluted earnings per share from continuing operations was TWD 0.85 compared to TWD 1.73 a year ago.
SYN-TECH Chem. & Pharm. Co., Ltd. is a Taiwan-based company principally engaged in the production, processing and distribution of active pharmaceutical ingredients (APIs). The Companyâs main products consist of muscle relaxants, local anesthetics, cardiovascular agents, antipyretics, analgesics and anti-inflammatory drugs, antimicrobials, spirit stabilizers, intermediates and others. It is also engaged in the pharmaceutical agency business. The Company distributes its products within Taiwan market and to overseas markets, including Asia, Europe, the Americas and Africa.
SYN-TECH CHEM. & PHARM. CO., LTD. 
